GSDMD and central nervous system cancer: Because B cells [28] and CD4+ T cells [29] usually inhibit tumor growth while CAFs [30] and macrophages [30] promote tumor growth, it was concluded that high levels of GSDMD induced an immunosuppressive microenvironment and promoted glioma progression.